Jpmorgan Chase & CO Burning Rock Biotech LTD Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$0.68 - $0.97 $816 - $1,164
1,201 New
1,201 $0
Q3 2023

Nov 14, 2023
SELL
$0.91 - $2.29 $5 - $13
-6 Reduced 2.69%
217 $0
Q2 2023

Aug 11, 2023
BUY
$2.15 - $3.16 $479 - $704
223 New
223 $0
Q4 2021

Feb 10, 2022
SELL
$9.43 - $17.14 $802,106 - $1.46 Million
-85,059 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$17.37 - $27.92 $1.48 Million - $2.37 Million
85,059 New
85,059 $1.52 Million

Others Institutions Holding BNR

# of Institutions
1
Shares Held
21.2K
Call Options Held
0
Put Options Held
0
View Full List

About Burning Rock Biotech Ltd

BNR Quotes by TradingView
  • Ticker BNR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 105,188,000
  • Market Cap $692M
  • Description
  • Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...
More about BNR
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email